CLINICAL GUIDELINES RADIATION ONCOLOGY

AIM General Clinical Guideline

OPEN THE GENERAL CLINICAL GUIDELINE

 

AIM Clinical Appropriateness Guidelines for Radiation Oncology

The foundation of our solution platform for specialty benefits management is our clinical appropriateness guidelines.

AIM Clinical Appropriateness Guidelines for Radiation Oncology are developed through a rigorous process integrating evidence-based literature with expert physician review. Included are guidelines for radiation therapy, proton beam therapy, radiopharmaceutical therapy, and hydrogel spacer for prostate radiotherapy.

The Guidelines do not address coverage, benefit or other plan specific issues. Applicable federal and state coverage mandates take precedence over these clinical guidelines. If requested by a health plan, AIM will review requests based on health plan medical policy/guidelines in lieu of the AIM Guidelines.

AIM Clinical Appropriateness Guidelines for Radiation Therapy

The treatments addressed in the AIM Clinical Appropriateness Guidelines for Radiation Therapy include brachytherapy, intensity-modulated radiation therapy, stereotactic body radiation therapy, and stereotactic radiosurgery.

For commercial, Medicare, and non-Anthem Medicaid members

OPEN THE GUIDELINES FOR RADIATION THERAPY

For Anthem Medicaid members

OPEN THE GUIDELINES FOR RADIATION THERAPY FOR ANTHEM MEDICAID

For commercial, Medicare, and Medicaid members

COMING SOON RADIATION THERAPY GUIDELINES EFFECTIVE APRIL 9, 2023

AIM Clinical Appropriateness Guidelines for Proton Beam Therapy

The treatment addressed in the AIM Clinical Appropriateness Guidelines for Proton Beam Therapy is proton beam therapy, also known as proton radiation therapy or proton radiotherapy.

OPEN THE GUIDELINES FOR PROTON BEAM THERAPY

AIM Clinical Appropriateness Guidelines for Therapeutic Radiopharmaceuticals

The treatments addressed in the AIM Clinical Appropriateness Guidelines for Therapeutic Radiopharmaceuticals include the most commonly used radiopharmaceutical drug therapies for oncologic conditions.

OPEN THE GUIDELINES FOR THERAPEUTIC RADIOPHARMACEUTICALS 

AIM Clinical Appropriateness Guidelines for Perirectal Hydrogel Spacer

The AIM Clinical Appropriateness Guidelines for Perirectal Hydrogel Spacer address the use of an implanted hydrogel spacer when radiation therapy is used to treat prostate cancer.

OPEN THE GUIDELINES FOR PERIRECTAL HYDROGEL SPACER FOR PROSTATE RADIOTHERAPY

 

Trouble viewing the guidelines?

To open our guidelines, your computer needs Adobe Reader, a free and trusted software that allows you to view PDFs.

GET ADOBE READER